Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011:2011:520816.
doi: 10.1155/2011/520816. Epub 2011 Dec 13.

The use of pluripotent stem cell for personalized cell therapies against neurological disorders

Hye-Yeong Ha  1 , Si-Hyong Jang, Ji-Won Jung
Affiliations
Review

The use of pluripotent stem cell for personalized cell therapies against neurological disorders

Hye-Yeong Ha et al. J Biomed Biotechnol. 2011.

Abstract

Although there are a number of weaknesses for clinical use, pluripotent stem cells are valuable sources for patient-specific cell therapies against various diseases. Backed-up by a huge number of basic researches, neuronal differentiation mechanism is well established and pluripotent stem cell therapies against neurological disorders are getting closer to clinical application. However, there are increasing needs for standardization of the sourcing pluripotent stem cells by establishing stem cell registries and banking. Global harmonization will accelerate practical use of personalized therapies using pluripotent stem cells.

PubMed Disclaimer

References

    1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–1147. - PubMed
    1. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872. - PubMed
    1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676. - PubMed
    1. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. Journal of Clinical Investigation. 2010;120(1):51–59. - PMC - PubMed
    1. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nature Cell Biology. 2011;13(5):497–505. - PMC - PubMed

Publication types

MeSH terms